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Abstract
Background: Relapse prevention is an important objective in the management of serious mental illness (SMI).
While community mental health nurses (CMHN) might be well-placed to support people with SMI in averting
relapse, no systematic reviews have examined this association.
Aim: To review the evidence from studies reporting an association between CMHN exposure and hospitalisation of
persons living with SMI (a proxy for relapse).
Methods: Searches were undertaken in ten bibliographic databases and two clinical trial registries. We included
studies of patients with SMI, where CMHN was the exposure, and the outcome was relapse (i.e. readmission to a
psychiatric inpatient facility). Quality assessment of included studies was completed using two risk-of-bias measures.
Results: Two studies met the inclusion criteria. Studies were rated as being of low-moderate methodological
quality. There was insufficient evidence to conclude that community mental health nursing reduced the risk of
admission to psychiatric inpatient facilities.
Conclusions: The review found no evidence that CMHN was associated with higher or lower odds of admission to
psychiatric inpatient facilities among patients with SMI. The findings of the review point to a need for further
research to investigate the impact of CMHN exposure and relapse in people with SMI.
Systematic review registration: PROSPERO CRD42017058694
Keywords: Hospital admission, Community mental health nursing, Mental illness, Relapse, Systematic review
Background
Mental illness is a global health priority, with at least
10% of the world’s population affected by a psychiatric
disorder at any one time [1]. The global cost of man-
aging these disorders approximated US$2.5 trillion in
2010, with expenditure expected to reach US$6.1 trillion
by 2030 [2]. The sizeable cost of mental illness, together
with the high prevalence and elevated risk of physical
morbidity and mortality in this population [3], contrib-
ute to considerable disease burden. In fact, mental illness
attributes to 32% of global disease burden in terms of
years lived with disability—more than any other condi-
tion [4].
Mental disorders vary in severity, from mild distur-
bances in thought and/or behaviour, to more serious
mental illness (SMI), such as schizophrenia, bipolar dis-
order and depression with psychotic features [5]. SMI
represents a group of non-organic psychotic disorders
that are both persistent (i.e. has a duration of treatment
of 2 years or more) and contribute to demonstrable dys-
function [6]. Compared with the general population,
people diagnosed with a SMI have a 1.4–2.0 times
higher risk of cardiovascular disease [5] and are more
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likely to be hospitalised [7], present to the emergency
department (2.9-fold increased risk) [8] and be victims
of crime (2.3 to 140-fold increased risk) [9]. Effective
support and management of SMI are essential to redu-
cing the burden of serious mental illness [10].
Over the past two decades, there has been a strong em-
phasis on the use of community-based services models
(e.g. crisis teams, early intervention services, case manage-
ment) to manage serious mental illness [11]. A primary
aim of these models is to offer intensive support at home
rather than admission to hospital, and when admission to
hospital does occur, to facilitate early discharge [12]. The
focus on relapse prevention is an important clinical out-
come for patients with SMI. Not only does preventing re-
lapse reduce the risk of future relapses, it may also
enhance quality of life and reduce distress for the patient
[13]. Furthermore, relapse is associated with considerable
cost to the health system [14]. For example, in the United
Kingdom (UK), it has been estimated that treatment costs
associated with relapse in the previous 6months are at
least four times higher than those for patients who have
not relapsed [15].
Community mental health nurses are appropriately
placed to avert relapse in people living with SMI. Anec-
dotal reports from groups of stakeholders in the UK
have indicated that community mental health nurses
have more face-to-face contact with individuals living
with SMI relative to other disciplines [16]. Hence, their
potential to impact the clinical outcomes of people with
SMI may be substantial [17, 18].
We found only one previous systematic review of the
effectiveness of community mental health nurses [19].
This review was published almost 25 years ago and in-
cluded 11 trials. Most included studies focused on the
testing of specific interventions (e.g. family work) and
not the impact of community mental health nursing as
the exposure of interest. The authors concluded that
their review did little to refute the idea that the efficacy
of community mental health nursing in relation to pa-
tient outcomes may something of a myth. There has
been no subsequent systematic review of the literature
on this topic. Other clinical disciplines (such as midwif-
ery) [20] have established a strong empirical case, clearly
demonstrating—in meta-analyses—better outcomes
compared with usual care. In mental health, a similar
evidence base is important in informing and planning
models of service delivery.
Methods
Aim
This systematic review aimed to investigate the associ-
ation between exposure to community mental health
nursing care and admission to hospital (a suitable proxy
for relapse) [20] in people with serious mental illness.
Study selection process
Observational studies (including case-control, cohort
and cross-sectional studies) and clinical trials (including
non-randomised controlled trials and randomised con-
trolled trials) [i.e. study design] examining the effect of
care provided by mental health nurses [i.e. exposure] to
community-dwelling patients with SMI (i.e. schizophre-
nia, bipolar disorder and major depression) [i.e. partici-
pants] were eligible for inclusion in this review. The
intervention could be compared with any other model of
care [i.e. comparator]. For this review, we defined a com-
munity mental health or psychiatric nurse as a person
holding a formal specialised qualification in psychiatric/
mental health nursing and had been registered, creden-
tialed or licenced to practise in that capacity (e.g. regis-
tered mental health/psychiatric nurse) and was working
primarily in the community. It is important to note that
while the review protocol did not explicitly mention
‘community’ mental health nurses, it was implied. Stud-
ies evaluating multidisciplinary team-based models of
care, specific mental health nurse administered clinical
interventions (e.g. family work, cognitive behavioural
therapy) or care provided in secure or other inpatient
settings were excluded. No restriction was applied to the
language or date of publication.
The MEDLINE [Ovid, 1946 to present] search strategy
is presented in Table 1. This strategy was adapted, as ne-
cessary, for the following databases: CINAHL [EBSCO-
Host, 1937 to present], PubMed [NCBI, 1966 to present],
EMBASE [Ovid, 1947 to present], Nursing & Allied
Health Database [ProQuest, inception to present], Health
Source: Nursing/Academic Edition [EBSCOHost, incep-
tion to present], PsycINFO [Ovid, 1806 to present], Ovid
Nursing [Ovid, 1946 to present], ProQuest Dissertations
and Theses Global [ProQuest, 1743 to present], The
Cochrane Library [1992 to present], and Web of Science
Table 1 MEDLINE search strategy
i. Mental health nurs$ [mp] OR psychiatric nurs$ [mh,mp]
ii. Severe mental illness [mp] OR mental disorders [mh] OR mental
illness [mp] OR schizo$ [mh,mp] OR bipolar disorder [mh] OR psychos?s
[mp] OR psychotic [mp] OR psychotic affective disorders [mh] OR
psychotic disorders [mh] OR psychotic depression [mp]
iii. Patient admission [mh] OR patient readmission [mh] OR hospital
admission [mp] OR hospital readmission [mp] OR unplanned
readmission [mp] OR hospitali?ation [mp] OR readmission rate [mp] OR
length of stay [mh] OR emergency department presentation [mp] OR
admission to home treatment [mp] OR access to crisis intervention [mp]
OR drop-in treatment [mp] OR drop-in care [mp] OR drop-in unit [mp]
OR drop-in centre [mp] OR home intervention [mp] OR home therapy
[mp] OR home care services [mh] OR home management [mp]
iv. Observational study [mh] OR cross-sectional studies [mh] OR cohort
studies [mh] OR longitudinal studies [mh] OR epidemiologic studies
[mh] OR case-control studies [mh] OR controlled clinical trial [mh] OR
randomized controlled trial [mh] OR non-randomised controlled trials as
topic [mh] OR quasi-experimental study [mp] OR clinical trial [mh] OR
comparative study [mh]
v. i AND ii AND iii AND iv
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[Clarivate Analytics, 1975 to present]. All databases were
searched from the date of inception to June 2017. The
reference lists of included publications, and articles citing
the included publications, were also hand searched to
identify potentially eligible studies. Clinical trial registries
(i.e. clinicaltrials.gov; WHO Clinical Trials) were searched
to identify any on-going or unpublished trials. The search
strategy was initially implemented in July 2017 and
updated in November 2019.
Publications identified through the searches were
exported into reference management software (EndNote
X8, Clarivate Analytics, Boston, USA). Duplicate records
were excluded. The reference management file was sub-
sequently exported to systematic review software (Covi-
dence, Veritas Health Innovation, Melbourne, Australia)
for screening. Titles and abstracts of all identified publi-
cations were screened for eligibility against the review
selection criteria (i.e. eligible study design, participants,
exposure and outcomes) by two reviewers (a process
shared by all reviewers), independently. Remaining pub-
lications underwent full-text screening by two reviewers
(a process shared by all reviewers), independently. At
both stages of the process, disagreements were arbitrated
by a third reviewer.
Outcomes
The primary outcome of interest was hospital admission
(i.e. admission/readmission to a psychiatric inpatient facil-
ity), which served as a proxy for SMI relapse. This out-
come was selected because it is associated with a
deterioration in health and social exclusion; it is also the
primary focus of community psychiatric services, is widely
used in mental health services research and is economic-
ally meaningful [21]. Secondary outcomes were hospital
length of stay, emergency department presentations, crisis
team referral, duration of crisis team treatment, crisis
house referral, detention under mental health law and ad-
verse events.
Data extraction
Data from eligible publications were extracted using a
customised data extraction tool. The tool collected infor-
mation on study characteristics, research methodology,
participant characteristics, interventions, comparators,
outcomes, results and new references. Data extraction
was performed by three reviewers (ML, MJ, RG), inde-
pendently, with disagreements adjudicated by a fourth
reviewer (AE).
Risk of bias
The risk of bias of observational studies was assessed
using the Risk Of Bias In Non-randomised Studies of In-
terventions (ROBINS-I) tool [22]. The ROBINS-I tool de-
termines the risk of bias across seven distinct domains,
including baseline and time-varying confounding, inter-
vention classification, co-interventions, participant selec-
tion, outcome measurement, missing data and selective
reporting bias. Two reviewers (ML, RG) independently
evaluated the risk of bias and rated studies as having a
low, moderate, severe, critical or unclear risk of bias. A
third reviewer (MJ) was consulted if there was disagree-
ment between reviewers.
The risk of bias of clinical trials was evaluated using
the Cochrane Collaboration risk of bias tool [23]. The
Cochrane tool assesses risk across seven domains, in-
cluding allocation concealment, sequence generation,
blinding of participants, personnel and outcome asses-
sors, selective outcome reporting, incomplete outcome
data and other sources of bias. Two reviewers (ML, RG)
independently rated the risk of bias for each item as low,
unclear or high risk. A third reviewer (MJ) was invited
to arbitrate when consensus was not reached between
reviewers.
Data synthesis
Given the considerable methodological heterogeneity of
studies and that no single comparable outcome was re-
ported in more than three studies, results could not be
combined by means of meta-analysis. The results were
instead presented using narrative synthesis. This synthe-
sis was undertaken by one reviewer (ML) and cross-
checked by two others (RG, MJ).
Registration and reporting guidelines
This review was prospectively registered with PROS-
PERO [CRD42017058694]. A detailed summary of the
review methods is set out in the protocol, which has
been published elsewhere [24]. The review is also re-
ported in accordance with PRISMA reporting guidelines
for systematic reviews [25].
Results
Search results
The search identified 1153 publications, of which 258
duplicates were removed (Fig. 1). During title/abstract
screening, 860 publications were excluded. At full-text
screening, a further 32 publications were excluded,
mostly because they reported the wrong intervention
(N = 24). Three publications, reporting two discrete
studies, met the selection criteria and were included in
the review.
Description of studies
Both included studies were conducted in community
settings in England (Table 2). One was an observational
study [26], the other a randomised controlled trial [27,
28]. Duration of follow-up was 18 months [27, 28] and 3
years [26].
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Description of participants
The 2 studies involved a total of 356 patients with ser-
ious mental illness. McCrone et al. [27]/Muijen et al.
[28] restricted their sample to patients with psychotic
disorders, whilst Barr et al. [26] included all patients
with a SMI. Participants were primarily middle-aged,
and just over half were male (gender was not reported in
the Barr et al. [26] study).
Description of interventions
Both studies reported community mental health nurs-
ing as the intervention under investigation. However,
there were differences between the two interventions.
Barr et al. [26] examined the association between com-
munity psychiatric nurse (CPN) contact and psychiatric
admission versus no CPN contact. McCrone et al. [27]/
Muijen et al. [28] compared the effect of intensive CPN
support, as measured by increased CPN contact time,
versus traditional CPN support. Patients in the inten-
sive support team received twice the amount of contact
with CPNs than patients in the traditional CPN group.
Table 2 provides additional, albeit limited details (due
to insufficient reporting in the publications), of the in-
terventions used in this study.
Description of outcomes
The two studies reported distinct outcomes, two of
which were relevant for this review: admission to hos-
pital [26] and health service use (i.e. hospital admissions
and emergency department presentations) [27, 28].
Assessment of risk of bias
The methodological quality of Barr et al. [26] was ap-
praised using ROBINS-I (Table 3). The study was found
to be of moderate methodological quality, with six of the
seven parameters having a moderate risk of bias. Of note,
was the high risk of confounding, as the authors made no
adjustments for confounders in their analysis. The
Cochrane risk of bias tool was used to appraise the
McCrone et al. [27]/Muijen et al. [28] trial, which was
found to be of low methodological quality (Table 3). The
study received an uncertain rating for four (allocation con-
cealment, sequence generation, blinding of participants,
blinding of assessors) of the seven parameters on the
Cochrane risk of bias tool. Both studies were more than a
decade old, with Barr et al. [26] published 18 years ago
and McCrone et al. [27]/Muijen et al. [28] published 24
years ago. Accordingly, these studies predate the introduc-
tion of quality standards for the reporting of clinical trials.
Fig. 1 Flow chart of study selection process
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Table 2 Characteristics of included studies
Authors Country Study design
(duration)
Setting Intervention Control Study population Outcomes
Barr et al.
[26]
England Observational
study (3 years)
Six general
practices (one
randomly
selected practice
from each
health locality in
an English
health district)
Community mental
health nurse contact
with patients on the
severe and enduring
mental illness registers
of included general
practices
No contact with a
community
mental health
nurse
N = 274
Inclusion criteria:
participants with
severe and enduring
mental illness (SEMI),
listed on the SEMI
register of included
general practices
Exclusion criteria: not
stated
Mean age: 45.4 ± 12.2
years
Gender: not specified
Dropouts: not
applicable
Admission to
psychiatric hospital,
frequency of
community mental
health nurse contacts
McCrone
et al. [27],
Muijen
et al. [28]
England Randomised
controlled
trial with two
parallel arms
(18 months)
Community
setting within
the Greenwich
health authority
Community support
team (comprising three
community psychiatric
nurses (CPNs), a team
leader and four
unqualified mental
health workers). Each
CPN acted as a care
manager/client
advocate. [None of the
unqualified mental
health workers
provided services to
the research group of
41 clients.]
Generic team
(comprising six
generic CPNs
who worked
independently,
but were often
attached to GP
practices).
N = 82
Inclusion criteria:
patients with a
psychotic disorder
(schizophrenia or
affective psychosis)
lasting more than 2
years, at least 2
hospital admissions in
the previous 2 years,
aged 18–64 years,
living in the Greenwich
health district
Exclusion criteria:
patients with primary
organic disorders
Mean age: 37 ± 11
years
Gender: 56.1% male
Dropouts: 10 (24%)
patients in the
intervention group and
14 (34%) patients in
the control group
dropped out, for the
following reasons: 20
refused to participate,
2 moved away, 1 could
not be found and 1
was in prison
Health service use,
Global Adjustment
Scale, Present State
Examination, Brief
Psychiatric Rating
Scale, Social
Adjustment Scale,
patient and carer
satisfaction, health
service costs,
accommodation costs,
community psychiatric
nurse costs
Table 3 Risk of bias of included studies
Study Risk Of Bias In Non-randomised Studies of Interventions (ROBINS-I) tool (for observational studies)
Confounding Participant
selection
Intervention
classification
Co-intervention Missing data Outcome
measurement
Selective
reporting
Barr et al. [26] High risk Moderate risk Moderate risk Moderate risk Moderate
risk
Moderate risk Moderate
risk
Study Cochrane risk of bias tool (for randomised controlled trials)
Sequence
generation
Allocation
concealment
Blinding
(participants/
personnel)
Blinding (outcome
assessors)
Objective
outcome
All outcomes
reported
Possible
biases
McCrone et al. [27],
Muijen et al. [28]
Unclear risk Unclear risk Unclear risk Unclear risk Low risk Low risk High risk
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Effects of interventions
Hospital admission rates
Two studies reported psychiatric inpatient admission
rates as an outcome. Barr et al. [26] reported more psy-
chiatric admissions in patients receiving community psy-
chiatric nurse care at 3 years follow-up compared with
patients that had no CPN contact (81% vs. 19% of sam-
ple, respectively). McCrone et al. [27], on the other
hand, reported fewer admissions in patients receiving in-
tensive community psychiatric nurse support team care
at 12–18 months compared with patients receiving gen-
eric CPN care (0% vs. 10% of sample, respectively). By
contrast, Muijen et al. [28] reported no significant differ-
ence in the mean number of hospital admissions be-
tween the intensive and generic CPN care groups at 12–
18months (0.4 admissions in each group). It is assumed
that hospital admissions in this study referred to admis-
sion to general and not psychiatric settings.
Emergency department (ED) presentations
One study (McCrone et al. [27] or Muijen et al. [28]) re-
ported ED presentations as an outcome. McCrone et al.
[27]/Muijen et al. [28] found patients in the generic
CPN care group were more likely to present at an emer-
gency department in the first 6 months of treatment
compared with patients in the intensive CPN care group
(6% vs. 3% of participants). However, there were no not-
able differences between the two groups at 6–12months
(3% vs. 3% of participants) and 12–18months (7% vs. 6%
of participants).
Other outcomes
The included studies did not report data on hospital
length of stay, crisis team presentations, admissions to
crisis houses, detention in hospital under mental health
law or adverse events.
Discussion
This review investigated the association between expos-
ure to community mental health nursing and hospital
admission among individuals living with SMI. The two
included studies, both conducted in the UK, were rated
as being of low to moderate methodological quality. The
findings were also inconsistent. One study reported in-
creased odds of admission to psychiatric inpatient facil-
ities among patients receiving CPN care (versus no CPN
care) [26]. The other study found no difference in the
rates of psychiatric inpatient admissions between pa-
tients receiving generic and intensive CPN care [28].
Hence, the effect of community mental health nursing
care on hospital admission (or relapse) prevention in
people with SMI is inconclusive.
The paucity of studies examining the association be-
tween exposure to community mental health nursing
and hospital admission in people with SMI should not
be viewed as a limitation, but rather an opportunity. The
review has uncovered an important evidence gap in the
field, highlighting the need for methodologically rigorous
research aimed at better understanding the impact of
mental health nursing care [29]. We would therefore
argue that the findings of our review provide an import-
ant impetus for future investment in mental health nurs-
ing research and education.
It is surprising that there have been so few relevant
studies at a time when nursing workforce research in
general settings has been the focus of a number of im-
portant and influential studies [30] and reviews [31]. It is
also noteworthy that the studies included in our review
were all from the UK. It is difficult to offer an informed
insight as to why this might be. Perhaps researchers and
funders do not recognise the value of better understand-
ing the impact of the community mental health nurses
on patient outcomes.
Some qualitative studies have reported that patients
value the contribution that mental health nurses make
to their care and treatment. In a review of 17 reports on
the Australian Mental Health Nurse Incentive program,
Happell and Phung [32] concluded that mental health
nurses benefited the health of people with mental illness
with respect to increasing access to primary care. This is
in contrast to the predominantly negative findings from
a qualitative study of 23 Australian mental health nurse
graduates [33], in which participants reported that men-
tal health nursing staff were uncaring, and patients were
often neglected, and in some cases, mistreated.
Rather than focussing on the strengths and limitations
of the existing mental health nursing workforce, a num-
ber of randomised controlled trials (RCTs) in the UK
have explored whether changes in mental health nursing
education (i.e. training to deliver specific evidence-based
interventions) could impact patient outcomes. The evi-
dence from these studies has been largely positive. For
example, in a meta-analysis of 53 RCTs involving 2981
patients with schizophrenia, Pharoah et al. [34] found
that educating mental health workers (from non-specific
disciplines) to work with the families of people living
with schizophrenia was effective in reducing patient re-
lapse, increasing adherence with medication and redu-
cing admission to hospital. Nevertheless, these studies
do not provide evidence specifically related to mental
health nursing. There is a clear need to better under-
stand optimal nursing skill mix in community mental
health settings. A research question of primary import-
ance would be to understand the association between
skill mix (e.g. ratio of nurses to other health profes-
sionals) in community mental health teams and patient
outcomes (of which admission to acute care is used as a
proxy for relapse).
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Limitations
The focus of this review was on hospital readmission of
patients with SMI. The review did not include studies
that focused on quality of life, recovery, reduced suicide
risk, vocational needs or overall satisfaction with care—
all of which are areas where community mental health
nursing may have played an important role. While ad-
mission to hospital was used as a proxy measure for re-
lapse of SMI, this may not be an accurate measure of
relapse since home treatment or crisis teams have been
part of standard care for people in mental health crisis
in the UK since 2000. In addition, people may be admit-
ted to psychiatric inpatient facilities for clozapine initi-
ation, which may not represent a relapse of SMI.
However, admission to hospital has been used as a
measure of relapse in other studies [35] and is an object-
ive outcome used in psychiatric services. The inclusion
of crisis teams as a proxy measure for relapse might
yield different results in future reviews, although the
view of the authors is that generating new primary data
should be the priority for future research.
Conclusions
Mental health nurses represent over half of the global
mental health workforce [36]. While nurses are often
cited in policy as being pivotal members of mental
health teams, this review found little evidence that ex-
posure to community mental health nurses was associ-
ated with lower odds of being admitted to psychiatric
inpatient care. Given the paucity of consistent, high-
quality evidence addressing the impact of community
mental health nursing on relapse in SMI and the
evidence-base supporting the practice of other disci-
plines and branches of nursing, there is a need to build
an evidence base to inform the planning of community
mental health services.
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